99 related articles for article (PubMed ID: 29684155)
1. Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors.
Falk JJ; Winkelmann M; Stöhr D; Alt M; Schrezenmeier H; Krawczyk A; Lotfi R; Sinzger C
J Infect Dis; 2018 Aug; 218(6):876-885. PubMed ID: 29684155
[TBL] [Abstract][Full Text] [Related]
2. A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus.
Falk JJ; Winkelmann M; Schrezenmeier H; Stöhr D; Sinzger C; Lotfi R
Transfusion; 2017 Feb; 57(2):412-422. PubMed ID: 27861998
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus.
Harnois MJ; Dennis M; Stöhr D; Valencia SM; Rodgers N; Semmes EC; Webster HS; Jenks JA; Barfield R; Pollara J; Chan C; Sinzger C; Permar SR
J Infect Dis; 2022 Nov; 226(9):1667-1677. PubMed ID: 35970817
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread.
Falk JJ; Winkelmann M; Laib Sampaio K; Paal C; Schrezenmeier H; Alt M; Stanton R; Krawczyk A; Lotfi R; Sinzger C
Viruses; 2018 Sep; 10(9):. PubMed ID: 30223489
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
7. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
Wang X; Peden K; Murata H
Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
[TBL] [Abstract][Full Text] [Related]
9. Strain-specific neutralization of human cytomegalovirus isolates by human sera.
Klein M; Schoppel K; Amvrossiadis N; Mach M
J Virol; 1999 Feb; 73(2):878-86. PubMed ID: 9882288
[TBL] [Abstract][Full Text] [Related]
10. Association of Human Immunoglobulin G1 Heavy Chain Variants With Neutralization Capacity and Antibody-Dependent Cellular Cytotoxicity Against Human Cytomegalovirus.
Vietzen H; Görzer I; Puchhammer-Stöckl E
J Infect Dis; 2016 Oct; 214(8):1175-9. PubMed ID: 27465644
[TBL] [Abstract][Full Text] [Related]
11. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
[TBL] [Abstract][Full Text] [Related]
12. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
[TBL] [Abstract][Full Text] [Related]
14. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry.
Murray MJ; Bonilla-Medrano NI; Lee QL; Oxenford SJ; Angell R; Depledge DP; Reeves MB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941787
[TBL] [Abstract][Full Text] [Related]
15. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.
Pati SK; Novak Z; Purser M; Arora N; Mach M; Britt WJ; Boppana SB
Clin Vaccine Immunol; 2012 Jun; 19(6):909-13. PubMed ID: 22492744
[TBL] [Abstract][Full Text] [Related]
16. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
[TBL] [Abstract][Full Text] [Related]
17. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
[TBL] [Abstract][Full Text] [Related]
19. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
